Home / Norepinephrine / Canada
CA ATC C01CA03 · updated 2 Nov 2026
Norepinephrine shortage in Canada
Is there a Norepinephrine shortage in Canada?
Yes. As of 2 Nov 2026, 1 Norepinephrine product is reported short in Canada, the first since 2 May 2022. No return date has been given. Main reason: manufacturing problem.
Also short in Belgium, Czechia, Sweden, New Zealand. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | NOREPINEPHRINE BITARTRATE INJECTION USP (1mg/ml 4 ml ampoule, pack of ten ampoules) | GENERIC MEDICAL PARTNERS INC | 2 May 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.